Company Filing History:
Years Active: 2002
Title: Joseph D. Rosenblatt: Innovator in HTLV-II Detection Methods
Introduction
Joseph D. Rosenblatt is a notable inventor based in Los Angeles, CA. He has made significant contributions to the field of medical diagnostics, particularly in the detection of human T-cell lymphotropic virus type II (HTLV-II). His work has implications for understanding and diagnosing certain types of leukemia.
Latest Patents
Rosenblatt holds a patent for "Methods for the detection of HTLV-II antibodies employing novel HTLV-II NRA envelope peptides." This invention relates to a novel HTLV-II isolate designated NRA, which was originally isolated from a patient with atypical hairy cell leukemia. The patent details the genetic differences between this isolate and the prototypical HTLV-II isolate Mo. It focuses on the gp46 and p21 envelope proteins encoded by the env gene, providing methods and kits for the detection of HTLV-II antibodies using these proteins.
Career Highlights
Joseph D. Rosenblatt has been associated with Abbott Laboratories Corporation, where he has contributed to advancements in medical technology and diagnostics. His work has been pivotal in enhancing the understanding of HTLV-II and its implications in human health.
Collaborations
Rosenblatt has collaborated with notable colleagues, including Helen H. Lee and Priscilla Swanson. Their combined efforts have furthered research in the field of virology and antibody detection.
Conclusion
Joseph D. Rosenblatt's innovative work in the detection of HTLV-II antibodies showcases his commitment to advancing medical diagnostics. His contributions are vital for improving the understanding and treatment of related health conditions.